ClinicalTrials.Veeva
Menu

Find clinical trials for Chronic Lymphocytic Leukemia in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Leukemia
Mantle-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Lymphoma

Chronic Lymphocytic Leukemia trials near Cincinnati, OH, USA:

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

Multicenter Parallel 2 Cohort Phase 2 Study of LP-168 and Obinutuzumab for Previously Treated, and T474 Gatekeeper Mutant Chronic Lymphocytic...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Drug: LP-168
Drug: Obinutuzumab

Phase 2

Zulfa Omer

Cincinnati, Ohio, United States

Locations recently updated

This study will evaluate the long-term safety of pirtobrutinib in participants with previously treated chronic lymphocytic leukemia...

Enrolling
Lymphoma, Small Lymphocytic
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: Idelalisib

Phase 4

Lilly
Lilly

Cincinnati, Ohio, United States of America and 48 other locations

Locations recently updated

or venetoclax plus rituximab retreatment) in participants with chronic lymphocytic leukemia (CLL) or small lymphocytic...

Enrolling
Chronic Lymphocytic Leukemia
CLL
Drug: Bendamustine
Drug: Rituximab

Phase 3

BeOne Medicines

Dayton, Ohio, United States and 127 other locations

The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing o...

Active, not recruiting
Small Lymphocytic Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Drug: Venetoclax
Drug: Ibrutinib

Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Cincinnati, Ohio, United States of America and 74 other locations

The main purpose of Part 1 of this study is to assess the efficacy and safety of 3 dose levels of Pirtobrutinib in participants with chronic ...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib

Phase 2

Loxo Oncology
Loxo Oncology

Edgewood, Kentucky, United States and 131 other locations

Epcoritamab will be tested either inRelapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) as:* Monotherapy, or* Com...

Active, not recruiting
Small Lymphocytic Lymphoma
Treatment-naïve High Risk Chronic Lymphocytic Leukemia
Drug: Lenalidomide
Drug: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

Phase 1, Phase 2

Genmab
Genmab

Cincinnati, Ohio, United States and 80 other locations

Locations recently updated

The goal of this study is to evaluate nemtabrutinib compared with investigator's choice of ibrutinib or acalabrutinib in participants with chronic...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Nemtabrutinib
Drug: Acalabrutinib

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Edgewood, Kentucky, United States and 200 other locations

Locations recently updated

with pirtobrutinib in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: BGB-16673

Phase 3

BeOne Medicines

Dayton, Ohio, United States and 204 other locations

The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Venetoclax
Drug: Rituximab

Phase 3

Loxo Oncology
Loxo Oncology

Cincinnati, Ohio, United States of America and 179 other locations

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: Bendamustine

Phase 3

Loxo Oncology
Loxo Oncology

Cincinnati, Ohio, United States of America and 233 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems